 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/08/2026 |
$2.51 |
$2.54 |
$2.38 |
$2.45 |
128.00K | | 07/09/2026 |
$2.42 |
$2.42 |
$2.27 |
$2.36 |
144.10K | | 07/10/2026 |
$2.37 |
$2.39 |
$2.22 |
$2.37 |
65.70K | | 07/13/2026 |
$2.37 |
$2.42 |
$2.21 |
$2.40 |
177.60K | | 07/14/2026 |
$2.35 |
$2.36 |
$2.23 |
$2.26 |
157.70K |
 |
| Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. Its lead drug candidate under development is oral (Z)-endoxifen, which it is developing for both the prevention and treatment of breast cancer. (Z)-endoxifen is the potent Selective Estrogen Receptor Modulator for estrogen receptor inhibition and causes estrogen receptor degradation. In addition to its potent anti-estrogen effects, (Z)-endoxifen has been shown to target PKCB1, a known oncogenic protein, at clinically attainable blood concentrations. | |
 |

Atossa Therapeutics (ATOS) has the following price history information. Looking back at ATOS historical stock prices for the last five trading days, on July 08, 2026, ATOS opened at $2.51, traded as high as $2.54 and as low as $2.38, and closed at $2.45. Trading volume was a total of 128.00K shares. On July 09, 2026, ATOS opened at $2.42, traded as high as $2.42 and as low as $2.27, and closed at $2.36. Trading volume was a total of 144.10K shares. On July 10, 2026, ATOS opened at $2.37, traded as high as $2.39 and as low as $2.22, and closed at $2.37. Trading volume was a total of 65.70K shares. On July 13, 2026, ATOS opened at $2.37, traded as high as $2.42 and as low as $2.21, and closed at $2.40. Trading volume was a total of 177.60K shares. On July 14, 2026, ATOS opened at $2.35, traded as high as $2.36 and as low as $2.23, and closed at $2.26. Trading volume was a total of 157.70K shares.
ATOS Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Atossa Therapeutics shares, starting with a $10,000 purchase of ATOS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/18/2016 |
|
| End date: |
07/14/2026 |
|
| Start price/share: |
$756.00 |
|
| End price/share: |
$2.26 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.70% |
|
| Average Annual Total Return: |
-44.10% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$29.89 |
|
| Years: |
9.99 |
|
|
 |
| Date |
Close |
| 07/08/2026 | $2.45 | | 07/09/2026 | $2.36 | | 07/10/2026 | $2.37 | | 07/13/2026 | $2.40 | | 07/14/2026 | $2.26 |
|
 |